Ernexa Therapeutics Inc. Litigation Settlement, Amount Awarded to Other Party
Ernexa Therapeutics Inc. (ERNA) reported Litigation Settlement, Amount Awarded to Other Party of $500.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2024-03-14
- Ernexa Therapeutics Inc. litigation settlement, amount awarded to other party for fiscal 2023 was $500.00K, a 58.33% decline from fiscal 2022.
- Ernexa Therapeutics Inc. litigation settlement, amount awarded to other party for fiscal 2022 was $1.20M.
| Period end | Litigation Settlement, Amount Awarded to Other Party | Litigation Settlement, Amount Awarded to Other Party 12 month |
|---|---|---|
| 2023-12-31 | $500.00K 10-K · filed 2024-03-14 | |
| 2022-12-31 | $1.20M 10-K · filed 2024-03-14 | |
| 2022-08-05 | $1.20M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |